These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1748538)

  • 1. Pharmacokinetics of intravenous metronidazole at different dosages in healthy subjects.
    Lau AH; Emmons K; Seligsohn R
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):386-90. PubMed ID: 1748538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and bioavailability of metronidazole after tablets, suppositories and intravenous administration.
    Bergan T; Leinebo O; Blom-Hagen T; Salvesen B
    Scand J Gastroenterol Suppl; 1984; 91():45-60. PubMed ID: 6588489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of metronidazole in saliva.
    Mustofa ; Suryawati S; Santoso B
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):474-8. PubMed ID: 1813432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of metronidazole and its major metabolite after a high intravenous dose.
    Bergan T; Aase S; Leinebo O; Harbitz T; Olsen A; Liavag I
    Scand J Gastroenterol Suppl; 1984; 91():113-23. PubMed ID: 6588488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole.
    Sprandel KA; Drusano GL; Hecht DW; Rotschafer JC; Danziger LH; Rodvold KA
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):303-9. PubMed ID: 16887471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
    Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
    Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high-dose metronidazole on pharmacokinetics of oral budesonide and vice versa: a double drug interaction study.
    Dilger K; Fux R; Röck D; Mörike K; Gleiter CH
    J Clin Pharmacol; 2007 Dec; 47(12):1532-9. PubMed ID: 18048573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of metronidazole in hospitalized patients.
    Lau A
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):643-5. PubMed ID: 3818143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term sucralfate administration does not alter the absorption of metronidazole in healthy male volunteers.
    Moraes ME; Pierossi Mde A; Moraes MO; Bezerra FF; Da Silva CM; Dias HB; Muscará MN; De Nucci G; Pedrazzoli Júnior J
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):433-7. PubMed ID: 8897081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of metronidazole given to horses by intravenous and oral routes.
    Sweeney RW; Sweeney CR; Soma LR; Woodward CB; Charlton CA
    Am J Vet Res; 1986 Aug; 47(8):1726-9. PubMed ID: 3752681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole.
    Rajnarayana K; Reddy MS; Vidyasagar J; Krishna DR
    Arzneimittelforschung; 2004; 54(2):109-13. PubMed ID: 15038460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative bioavailability of two tablet preparations of metronidazole.
    Paton DM; Webster DR
    Int J Clin Pharmacol Res; 1988; 8(4):227-9. PubMed ID: 3182111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of metronidazole after rectal administration in horses.
    Garber JL; Brown MP; Gronwall RR; Merritt K
    Am J Vet Res; 1993 Dec; 54(12):2060-3. PubMed ID: 8116938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration.
    Lakritz J; Wilson WD; Mihalyi JE
    Am J Vet Res; 1999 Apr; 60(4):414-9. PubMed ID: 10211682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose pharmacokinetics and genotoxicity of metronidazole in cats.
    Sekis I; Ramstead K; Rishniw M; Schwark WS; McDonough SP; Goldstein RE; Papich M; Simpson KW
    J Feline Med Surg; 2009 Feb; 11(2):60-8. PubMed ID: 19155181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
    Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
    Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.